is semaglutide on shortage list and Tirzepatide off FDA list: What does this mean for weight loss drug access? FDA Announces End to Semaglutide

Compounded semaglutide is a customized GLP-1 (glucagon-like peptide-1) drug, made by compounding pharmacies and personalized for individual use

Understanding when to seek assistance or when a symptom is typical reduces the risk that someone will discontinue treatment due to concern or distress

In the case of Mounjaro after 11 months on the market, transitional assistance accounts for a quarter of all commercial new starts and more than half of all commercial claims as continuing patients become repeat beneficiaries of transitional assistance

L-carnitine is a molecule involved in the oxidation of fatty acids in the mitochondria

If side effects are severe during month one, do not discontinue semaglutide without medical guidance